As one of the goals of this study is to provide support for tumour testing as a potential way to triage patients for genetic counselling and follow-up germline testing, including TP53 pathologic variants would flag high numbers of patients for further testing and would not be practical in our healthcare system. Here, TP53 is linked to neoplasm.